Viewing Study NCT00025467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-30 @ 4:12 PM
Study NCT ID: NCT00025467
Status: COMPLETED
Last Update Posted: 2013-01-24
First Post: 2001-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Adenoacanthoma View
None Endometrial Adenocarcinoma View
None Endometrial Adenosquamous Cell Carcinoma View
None Endometrial Clear Cell Carcinoma View
None Endometrial Papillary Serous Carcinoma View
None Recurrent Endometrial Carcinoma View
Keywords: